Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Genetically Modified Pig Kidney Keeps Patient Off Dialysis for Nine Months
1+ week, 3+ day ago (418+ words) A genetically modified pig kidney kept a 66-year-old man with kidney failure off dialysis for a record nine months in the first transplant of its kind used as a "bridge" to a human organ transplant. The result offers hope amid…...
Biotech Startups Qualify for R&D Tax Credits More Often Than They Realize, K-38 Consulting Reports
2+ day, 7+ hour ago (86+ words) ...
Microbe patents???could unlock billions??? - Export Barbados
2+ day, 9+ hour ago (614+ words) The government’s move to patent a group of microbes discovered by UWI Cave Hill science researcher Dr Bidyut Mohapatra could create multi-billion-dollar opportunities for Barbados, the country’s export promotion chief has said. The push to patent began after Dr Mohapatra…...
FDA clears trial of dual-targeted CAR T-cell therapy for cancer
2+ day, 8+ hour ago (778+ words) The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to conduct a clinical trial testing genetically engineered immune cells in adults with advanced colorectal cancer and pediatric patients with solid cancers who…...
Anthropic Signs 24,000-Square-Foot Lease in Cambridge, Drawn by Proximity to Life Science Research | The Harvard Crimson
3+ day, 22+ min ago (498+ words) Anthropic, the artificial intelligence company behind Claude, is establishing its Cambridge base, signing a 24,000 square foot lease in Kendall Square, according to a Tuesday announcement. The long-term lease spans two floors of the One Kendall Square mixed-use office and lab…...
Encoded Therapeutics Raises $275 Million Series F To Advance Genetic Medicine For Dravet Syndrome
3+ day, 6+ hour ago (248+ words) Encoded Therapeutics has raised $275 million in Series F financing to advance ETX101 through pivotal development for Dravet syndrome and expand its precision genetic medicines pipeline for neurological disorders. The financing was co-led by GV and another healthcare fund, with participation from…...
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight
3+ day, 13+ hour ago (184+ words) New York, USA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight The CAR T-cell therapy for NHL clinical trial analysis report delivers important insights into ongoing research of 75+ pipeline CAR…...
FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer
3+ day, 14+ hour ago (801+ words) The FDA has cleared a CU Anschutz clinical trial of an experimental CAR T-cell therapy for advanced colorectal cancer and pediatric solid tumors. Developed at CU Anschutz, the therapy targets two pathways that help tumors grow and evade the immune…...
Frazier Life Sciences Adds $1.1B To Its Public Fund
3+ day, 13+ hour ago (58+ words) Law360 Try our Advanced Search for more refined results The Practice of Law Deep News & Analysis Law360 | The Practice of Law Law360 Authority | Deep News & Analysis Law360 Pulse | The Business of Law Frazier Life Sciences Adds $1.1B To Its Public Fund Law360 is on it, so…...
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer
3+ day, 13+ hour ago (847+ words) Sep 10, 2026, 15:15 ET CAR T-cells developed at CU Anschutz will target two pathways that help colorectal tumors grow and evade the immune system AURORA, Colo., Sept. 10, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration has granted permission for investigators at the University of…...